ClinVar Miner

Submissions for variant NM_001083116.3(PRF1):c.1349C>T (p.Thr450Met)

gnomAD frequency: 0.00003  dbSNP: rs189650890
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000547072 SCV000644878 pathogenic Familial hemophagocytic lymphohistiocytosis 2 2024-02-19 criteria provided, single submitter clinical testing This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 450 of the PRF1 protein (p.Thr450Met). This variant is present in population databases (rs189650890, gnomAD 0.01%). This missense change has been observed in individual(s) with familial hemophagocytic lymphohistiocytosis (PMID: 15632205, 15728124, 17266056, 18074390, 20092789, 21152410, 21881043, 25233452, 25297583, 26903364). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 468301). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PRF1 protein function. Experimental studies have shown that this missense change affects PRF1 function (PMID: 15632205, 19487666). For these reasons, this variant has been classified as Pathogenic.
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology RCV000547072 SCV000993625 pathogenic Familial hemophagocytic lymphohistiocytosis 2 2019-03-26 criteria provided, single submitter research
Revvity Omics, Revvity RCV001783053 SCV002024742 likely pathogenic not provided 2019-01-03 criteria provided, single submitter clinical testing
Baylor Genetics RCV003476292 SCV004204180 pathogenic Aplastic anemia 2024-02-21 criteria provided, single submitter clinical testing
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre RCV000547072 SCV004808173 pathogenic Familial hemophagocytic lymphohistiocytosis 2 2024-03-29 criteria provided, single submitter clinical testing
Genetics and Genomic Medicine Centre, NeuroGen Healthcare, NeuroGen Healthcare RCV000547072 SCV005873656 likely pathogenic Familial hemophagocytic lymphohistiocytosis 2 2020-08-23 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV005398810 SCV006057923 pathogenic Aplastic anemia; Familial hemophagocytic lymphohistiocytosis 2; Lymphoma, non-Hodgkin, familial 2023-01-16 criteria provided, single submitter research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.